Amgen (AMGN) Insider Trading & Ownership $287.87 +7.92 (+2.83%) (As of 11/20/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Amgen (NASDAQ:AMGN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.69%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$1.24 M Get AMGN Insider Trade Alerts Want to know when executives and insiders are buying or selling Amgen stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address AMGN Insider Buying and Selling by Quarter Ad DTIDownload Our Tesla Ebook For FreeLike many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. Amgen Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/17/2024Sheldon WhitehouseU.S. Congress Member (D-RI)Sell$332.80$1,001 - $15,0008/7/2024C. Scott FranklinU.S. Congress Member (R-FL)Buy$312.50$50,001 - $100,0008/2/2024C. Scott FranklinU.S. Congress Member (R-FL)Buy$333.99$1,001 - $15,0007/2/2024Kathy E. ManningU.S. Congress Member (D-NC)Buy$310.77$1,001 - $15,0005/3/2024Nancy A GrygielSVPSell2,117$313.09$662,811.53 1/23/2024Kathy E. ManningU.S. Congress Member (D-NC)Buy$309.91$1,001 - $15,0001/19/2024Tommy TubervilleU.S. Congress Member (R-AL)Sell$307.81$15,001 - $50,0001/2/2024Michael C. BurgessU.S. Congress Member (R-TX)Sell$297.39$15,001 - $50,00012/4/2023Nancy A GrygielSVPSell2,096$273.03$572,270.88 (Data available from 1/1/2013 forward) AMGN Insider Trading Activity - Frequently Asked Questions Who is on Amgen's Insider Roster? The list of insiders at Amgen includes Amgen Inc, Jonathan P Graham, Murdo Gordon, Nancy A Grygiel, R Sanders Williams, and Robert Eckert. Learn more on insiders at AMGN. What percentage of Amgen stock is owned by insiders? 0.69% of Amgen stock is owned by insiders. Learn more on AMGN's insider holdings. Which Amgen insiders have been buying company stock? The following insider purchased AMGN shares in the last 24 months: Amgen Inc ($29,999,985.00). How much insider buying is happening at Amgen? Insiders have purchased a total of 1,764,705 AMGN shares in the last 24 months for a total of $29,999,985.00 bought. Which Amgen insiders have been selling company stock? The following insiders have sold AMGN shares in the last 24 months: Jonathan P Graham ($2,728,100.00), Murdo Gordon ($2,508,305.94), and Nancy A Grygiel ($1,235,082.41). How much insider selling is happening at Amgen? Insiders have sold a total of 23,771 Amgen shares in the last 24 months for a total of $6,471,488.35 sold. Which members of congress are trading Amgen? C. Scott Franklin (R-FL) and Kathy E. Manning (D-NC) have bought shares of Amgen in the last year totaling $99,000. Sheldon Whitehouse (D-RI), Tommy Tuberville (R-AL), and Michael C. Burgess (R-TX) have sold shares totaling $73,000. Amgen Key ExecutivesMr. Robert A. Bradway (Age 61)Chairman & Chief Executive Officer Compensation: $6.73MMr. Peter H. Griffith (Age 65)Executive VP & CFO Compensation: $3.07MMr. Esteban Santos (Age 56)Executive Vice President of Operations Compensation: $3.01MDr. David M. Reese M.D. (Age 61)Executive VP & Chief Technology Officer Compensation: $3.4MMr. Murdo Gordon (Age 57)Executive Vice President of Global Commercial Operations Compensation: $3.24MMr. Matthew C. Busch (Age 50)Chief Accounting Officer & VP of Finance Mr. Mike ZahigianSenior VP & Chief Information OfficerDr. James E. Bradner M.D. (Age 52)Executive VP of Research and Development & Chief Scientific Officer Justin G. ClaeysVice President of Investor RelationsMr. Jonathan P. Graham (Age 63)Executive VP, General Counsel & Secretary Compensation: $2.44M More Insider Trading Tools from MarketBeat Related Companies Vertex Pharmaceuticals Insider Ownership Gilead Sciences Insider Ownership Regeneron Pharmaceuticals Insider Ownership Alnylam Pharmaceuticals Insider Ownership Biogen Insider Ownership United Therapeutics Insider Ownership Moderna Insider Ownership Incyte Insider Ownership Neurocrine Biosciences Insider Ownership BioMarin Pharmaceutical Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:AMGN) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amgen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amgen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
